These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37791546)

  • 21. Prognostic nutritional index and prognosis in renal cell carcinoma: A systematic review and meta-analysis.
    Kim SI; Kim SJ; Kim SJ; Cho DS
    Urol Oncol; 2021 Oct; 39(10):623-630. PubMed ID: 34253447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statin use improves the efficacy of nivolumab in patients with advanced renal cell carcinoma.
    Santoni M; Massari F; Matrana MR; Basso U; De Giorgi U; Aurilio G; Buti S; Incorvaia L; Rizzo M; Martignetti A; Maslov D; Tawagi K; Philon E; Blake Z; Porta C; Battelli N
    Eur J Cancer; 2022 Sep; 172():191-198. PubMed ID: 35780525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statins and renal cell carcinoma: Antitumor activity and influence on cancer risk and survival.
    Santoni M; Monteiro FSM; Massari F; Abahssain H; Aurilio G; Molina-Cerrillo J; Myint ZW; Zabalza IO; Battelli N; Grande E
    Crit Rev Oncol Hematol; 2022 Aug; 176():103731. PubMed ID: 35718065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncological outcome of surgical treatment in 336 patients with renal cell carcinoma.
    Zhang ZL; Li YH; Xiong YH; Hou GL; Yao K; Dong P; Liu ZW; Han H; Qin ZK; Zhou FJ
    Chin J Cancer; 2010 Dec; 29(12):995-9. PubMed ID: 21114919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of tumor size on patient survival after radical nephrectomy for pathological T3a renal cell carcinoma.
    Sugiyama Y; Yatsuda J; Murakami Y; Ito N; Yamasaki T; Mikami Y; Ogawa O; Kamba T
    Jpn J Clin Oncol; 2019 May; 49(5):465-472. PubMed ID: 30793163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statin use and the overall survival of renal cell carcinoma: A meta-analysis.
    Wu P; Xiang T; Wang J; Lv R; Zhuang Y; Wu G
    Clin Invest Med; 2020 Dec; 43(4):E17-23. PubMed ID: 33370521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
    Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
    BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncological control associated with surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma.
    Russell CM; Lue K; Fisher J; Kassouf W; Schwaab T; Sexton WJ; Tanguay S; Psutka SP; Thompson RH; Leibovich BC; Hanzly MI; Spiess PE; Boorjian SA
    BJU Int; 2016 Jun; 117(6B):E60-6. PubMed ID: 26118331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concurrent Use of Statins in Patients Undergoing Curative Intent Treatment for Triple Negative Breast Cancer: A Systematic Review and Meta-Analysis.
    McKechnie T; Brown Z; Lovrics O; Yang S; Kazi T; Eskicioglu C; Parvez E
    Clin Breast Cancer; 2024 Apr; 24(3):e103-e115. PubMed ID: 38296737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of survival and renal function between partial and radical laparoscopic nephrectomy for T1b renal cell carcinoma.
    Yang F; Zhou Q; Xing N
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):261-272. PubMed ID: 31677114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
    BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.
    Abu-Ghanem Y; Ramon J; Berger R; Kaver I; Fridman E; Leibowitz-Amit R; Dotan ZA
    World J Surg Oncol; 2017 Nov; 15(1):193. PubMed ID: 29096642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: conditional survival analysis.
    Abdollah F; Suardi N; Capitanio U; Matloob R; Fossati N; Castiglione F; Di Trapani E; Di Trapani D; Russo A; Carenzi C; Montorsi F; Rigatti P; Bertini R
    Urol Oncol; 2014 Jan; 32(1):43.e9-16. PubMed ID: 23911684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic review and meta-analysis of thermal ablation versus surgical nephrectomy for small renal tumours.
    Katsanos K; Mailli L; Krokidis M; McGrath A; Sabharwal T; Adam A
    Cardiovasc Intervent Radiol; 2014 Apr; 37(2):427-37. PubMed ID: 24482030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mortality Increases When Radical Nephrectomy is Delayed More Than 60 Days for T3 Renal Cell Carcinoma.
    Zhao F; Liu X; Zhang C; Zhu H; Qi N
    Technol Cancer Res Treat; 2021; 20():15330338211043963. PubMed ID: 34595976
    [No Abstract]   [Full Text] [Related]  

  • 37. A systematic review and meta-analysis of clinicopathologic factors linked to oncologic outcomes for renal cell carcinoma with tumor thrombus treated by radical nephrectomy with thrombectomy.
    Gu L; Li H; Wang Z; Wang B; Huang Q; Lyu X; Shen D; Gao Y; Fan Y; Li X; Xie Y; Du S; Liu K; Tang L; Peng C; Ma X; Zhang X
    Cancer Treat Rev; 2018 Sep; 69():112-120. PubMed ID: 29960124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive Nephrectomy.
    DiNatale RG; Xie W; Becerra MF; Silagy AW; Attalla K; Sanchez A; Mano R; Marcon J; Blum KA; Benfante NE; Voss MH; Motzer RJ; Coleman J; Choueiri TK; Reznik E; Russo P; Heng DYC; Hakimi AA
    Eur Urol Oncol; 2020 Feb; 3(1):47-56. PubMed ID: 31735646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overall survival and oncological outcomes after partial nephrectomy and radical nephrectomy for cT2a renal tumors: A collaborative international study from the French kidney cancer research network UroCCR.
    Reix B; Bernhard JC; Patard JJ; Bigot P; Villers A; Suer E; Vuong NS; Verhoest G; Alimi Q; Beauval JB; Benoit T; Nouhaud FX; Lenormand C; Hamidi N; Cai J; Eto M; Larre S; El Bakhri A; Ploussard G; Hung A; Koutlidis N; Schneider A; Carrouget J; Droupy S; Marchal S; Doerfler A; Seddik S; Matsugasumi T; Orsoni X; Descazeaud A; Pfister C; Bensalah K; Soulie M; Gill I; Flamand V;
    Prog Urol; 2018 Mar; 28(3):146-155. PubMed ID: 29331568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncologic and perioperative outcomes of laparoscopic versus open radical nephrectomy for the treatment of renal tumor (> 7 cm): a systematic review and pooled analysis of comparative outcomes.
    Wang L; Li KP; Yin S; Yang L; Zhu PY
    World J Surg Oncol; 2023 Feb; 21(1):35. PubMed ID: 36747217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.